| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Transcode Therapeutics, Inc. | Chief Technology Officer, 10%+ Owner | Stock Option (Right to Buy) | 60,000 | 12 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | 12 Dec 2022 | 1 | $0 | 4 | Chief Technology Officer, 10%+ Owner | 14 Dec 2022, 19:10 |
| RNAZ | Transcode Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Technology Officer, 10%+ Owner | 14 Dec 2022, 19:06 |
| RNAZ | Transcode Therapeutics, Inc. | 08 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 08 Jul 2021, 21:53 |